Background: Pulmonary Arterial Hypertension (PAH) is a rare, debilitating, and potentially fatal disease. This study aims to quantify the economic burden of PAH in Spain.
Methods: The study was conducted from a societal perspective, including direct and indirect costs associated with incident and prevalent patients.